advertising, promotions of a product or service, or patently offensive material will be forwarded promptly to the addressee. In the case of communications to our Board of Directors or any group or committee of directors, the Corporate Secretary will make sufficient copies and send one copy to each director who is a member of the group or committee to which the envelope is addressed.
Compensation Committee Interlocks and Insider Participation
None of the members of our Compensation Committee during fiscal 2020:
• | was an officer or employee of ours or any of our subsidiaries; |
• | was formerly an officer of ours or any of our subsidiaries; or |
• | (except as described herein) had any relationship requiring disclosure by us under the SEC’s rules requiring disclosure of related party transactions in this proxy statement. |
Insider Trading Policy — Hedging
Our insider trading policy provides that all directors, officers and employees of the Company and GECM and the executive officers and certain employees with access to financial information of Great Elm DME, Inc. (Covered Persons) and certain of their related persons may not engage in any hedging or monetization transactions, such as zero-cost collars and forward sale contracts, with respect to Company securities, including those granted to, or held directly or indirectly by, such Covered Persons. Further, such persons may not trade in options, warrants, puts and calls or similar instruments on Company securities or sell Company securities “short.”
Certain Relationships and Related Transactions
On September 7, 2018, we, through our wholly-owned subsidiary Great Elm DME Holdings, Inc. (“DME Holdings”), acquired an 80.1% equity interest in Great Elm DME, Inc. (“DME Inc.”), an entity formed to acquire and combine Valley Healthcare Holding, LLC and Northwest Medical, Inc. In connection with the acquisition, DME Holdings, Corbel Capital Partners SBIC, L.P. (“Corbel”), NWMI Manager LLC and Valley Healthcare Holdings, LLC entered into a transaction agreement. A member of our Board of Directors, Jeffrey S. Serota, serves as Vice Chairman to Corbel Capital Partners, an affiliate of Corbel. Corbel contributed partial funding of the $63.6 million transaction purchase price pursuant to a term loan in an aggregate principal amount of $25 million. As part of the consideration for the transaction, Corbel received a 9.95% non-controlling interest in DME Inc. as well as $5.0 million of preferred stock in DME Holdings. During the year ended June 30, 2019, this preferred stock was redeemed at its face value. In addition, the transaction agreement provided for up to $1.0 million in contingent consideration payments to Corbel. During the year ended June 30, 2019, we paid $0.3 million in partial satisfaction of this obligation. During the year ended June 30, 2020, no amounts were paid under this obligation and the obligation has terminated.
On June 12, 2019, we, through our majority-owned subsidiary, DME Inc., acquired certain assets and liabilities of Midwest Respiratory Care, Inc. In conjunction with the acquisition, Corbel contributed partial funding of the $6.3 million transaction purchase price consisting of $0.3 million in equity and additional term loans in an aggregate principal amount of $3.5 million.
All outstanding term loans from Corbel described above were paid in full on December 29, 2020.
On February 26, 2020, we issued $30 million aggregate principal amount of the PIK Notes. Funds managed by Imperial Capital Asset Management and Northern Right Capital Management, L.P., significant stockholders of the Company, and Mr. Scheyer’s affiliated trusts, each purchased the Notes.
In October 2020, GECM entered into a shared personnel and reimbursement agreement with Imperial Capital Asset Management, LLC (“ICAM”). Jason W. Reese, the Executive Chairman of our Board of Directors, is the Chief Executive Officer of ICAM. Costs incurred under this agreement are included in investment management expenses in our condensed consolidated statement of operations. For the three months ended December 31, 2020, such costs were $0.1 million.
On March 10, 2021, we issued $2.25 million of PIK Notes to MAST Capital in exchange for all outstanding obligations under the $3.1 million senior secured note issued by GP Corp. to MAST Capital, all common stock in GP Corp. held by MAST Capital and its affiliates, and termination of MAST Capital’s board appointment rights (the “MAST Transaction”). Separately, we repurchased the GP Corp. common stock held by certain of our employees for nominal consideration.